Missionomics Back to app

Basic Materials

Corteva, Inc. (CTVA)

Basic Materials $58.4B market cap

Data as of July 13, 2026

Environment
62.00
People
75.00
Leadership
68.00

Environment story

Corteva demonstrates moderate environmental commitment with persistent weaknesses in supply-chain transparency and greenwashing risk. Scope 3 emissions remain undisclosed; net-zero target year not disclosed in filings. The company faces ongoing litigation regarding pesticide safety (glyphosate-related suits following Monsanto's Roundup precedent) and environmental remediation liabilities from legacy EIDP operations, particularly PFAS contamination. Restructuring includes exit from Pittsburgh, California manufacturing facility, reportedly for operational optimization rather than emissions reduction. Cost and productivity initiatives mentioned but lack direct decarbonization infrastructure investment verification. Environmental accruals and indemnification assets ($242–$733 million) signal unresolved legacy liabilities. The 10-K acknowledges soil and groundwater contamination at multiple sites under ongoing remediation.

Criticisms on file

  • Glyphosate litigation risk: Company explicitly acknowledges trend in public and private suits alleging harm from crop protection products, specifically noting negative publicity and sentiment from Monsanto Roundup litigation. Claims could result in product discontinuation, reputation damage, and material adverse effect on business.
    Source: CTVA 10-K Risk Factors, Item 1A: 'Claims and allegations that Corteva's products or products that Corteva manufactures or markets on behalf of third parties are not safe could result in litigation, damage to Corteva's reputation and have a material adverse effect on Corteva's business.'
  • PFAS environmental remediation: Corteva incurs significant costs for PFAS environmental remediation activities primarily at Chemours' Fayetteville Works facility. Loss from discontinued operations after income taxes was $(99) million in 2025 driven largely by PFAS remediation charges and NJ Statewide Settlement.
    Source: CTVA 10-K MD&A, Item 7: 'Income (loss) from discontinued operations after income taxes was $(99) million for the year ended December 31, 2025. The after-tax charge was driven by charges recognized relating to the MOU with Chemours and DuPont, including a charge associated with the NJ Statewide Settlement as well as PFAS environmental remediation activities.'
  • Regulatory uncertainty and public opposition: Company faces increased litigation from public and environmental interest groups seeking to invalidate pesticide registrations, including Enlist One®, and challenge regulatory application. Acknowledges that regulatory standards are continuously changing and lack harmony could result in unintended noncompliance.
    Source: CTVA 10-K Risk Factors, Item 1A: 'Corteva has seen an increase in recent years in the number of lawsuits filed by those who identify themselves as public or environmental interest groups seeking to invalidate pesticide product registrations... The pace of change together with the lack of regulatory harmony could result in unintended noncompliance.'
  • Bayer litigation settlement: $610 million charge recorded in 2025 relating to resolution of litigation with Bayer, included in significant items.
    Source: CTVA 10-K MD&A, page 45, Significant Items reconciliation: 'Bayer resolution: $610 million.' Noted as pre-tax charge.
  • Indemnification liabilities for legacy environmental matters: Corteva maintains accruals for environmental remediation and restoration costs related to discontinued and divested EIDP operations. Indemnification assets of $242 million and $733 million recognized for cost-sharing and indemnification agreements with Chemours, DuPont, and Dow.
    Source: CTVA 10-K Risk Factors and MD&A: 'Corteva accrues for environmental matters when it is probable that a liability has been incurred and the amount can be reasonably estimated... As of December 31, 2025, the indemnification assets pursuant to the Chemours Separation Agreement and the Corteva Separation Agreement are in aggregate $242 million within accounts and notes receivable - net and $733 million within other assets.'

Disclosed initiatives

  • Crop Protection Operations Strategy Restructuring Program
    Announced November 2023; amended October 2024. Exit from Pittsburgh, California production facility and optimization of manufacturing network. Expected to record $650–$700 million in pre-tax charges through 2026.
    Expected $180 million run-rate savings by 2027; environmental impact unquantified.
  • Ongoing Environmental Compliance & Remediation
    Soil and groundwater contamiation monitoring, investigation and remediation at multiple sites. Company maintains voluntary programs to reduce air emissions, minimize hazardous waste, decrease water use and discharge, increase energy efficiency, and reduce persistent bioaccumulative toxic materials.
    Compliance-oriented; financial impact material and subject to considerable uncertainty per 10-K.
  • Product Development in Biologicals
    Increased R&D investment ($1,474 million in 2025, up from $1,402 million in 2024) to develop biological and chemical products that protect crops and enhance plant productivity.
    Portfolio diversification toward lower-impact solutions; quantified emissions benefit not disclosed.

Social story

Corteva demonstrates moderate social performance with material gaps in labor relations transparency and executive compensation disclosure. CEO-to-worker pay ratio not disclosed in filings. No documented union-suppression activities or major strikes reported within the 24-month window. Leadership diversity metrics not explicitly disclosed; company acknowledges diversity as part of sustainability strategy but provides no percentages. Supply-chain labor audits not verified in filings; no public commitment to living wages or modern slavery statement. Employee turnover rate not disclosed. R&D investment increased to $1,474 million (2025), signaling commitment to innovation; however, variable compensation expense and commissions increased materially, suggesting potential workforce volatility. Bad debt expense increased, potentially reflecting customer financial stress or credit tightening.

Criticisms on file

  • Increased bad debt expense and customer financing stress: SG&A expenses increased to $3,492 million in 2025 with material increase in bad debt expense, suggesting customer payment stress or credit tightening in seasonal financing programs.
    Source: CTVA 10-K MD&A, Item 7: 'The increase was primarily driven by an increase in commissions, variable compensation, bad debt expense, legal support fees and personnel and information technology costs.'
  • Variable compensation and commission volatility: Increased variable compensation and commissions noted across R&D and SG&A, indicating potential workforce compensation volatility and incentive structure changes.
    Source: CTVA 10-K MD&A, Item 7: 'R&D expense increase... primarily driven by higher employee compensation costs due to variable compensation increases, as well as higher contractor, consulting and field, lab and facilities costs.' and 'SG&A expenses increase... primarily driven by an increase in commissions, variable compensation...'
  • Undisclosed workforce diversity and turnover metrics: Company's sustainability strategy references diversity commitments, but no quantitative diversity percentages, gender pay gap, or turnover rates disclosed in 10-K filing.
    Source: CTVA 10-K Risk Factors, Item 1A: 'Sentiment towards sustainability matters could adversely affect our stock price, results of operations, and access to capital. Corteva has established certain strategies, commitments and initiatives as part of its sustainability programs.' (Specific metrics not provided in filed documents).

Disclosed initiatives

  • Research and Development Investment
    R&D expense increased to $1,474 million in 2025 from $1,402 million in 2024, driven by higher employee compensation costs due to variable compensation increases, contractor, consulting, and field/lab/facilities costs.
    Support for long-term growth and innovation; employee compensation increases indicate wage pressure.
  • Seasonal Customer Financing Programs
    Company offers customers financing programs with credit terms generally less than one year aligned with growing season. Third-party customer financing programs established in U.S., Latin America, Europe, and Asia with annual renewal.
    Supports smallholder and underfinanced farmer access to products; company guarantees portion of credit extension in some cases.
  • Stoller and Symborg Acquisitions
    March 2023 acquisitions completed; acquisition-related costs recorded as significant items in 2023 and 2024.
    Portfolio expansion in biological and specialty products; integration costs and fair-value inventory step-up recognized.
  • Restructuring and Severance Programs
    Crop Protection Operations Strategy Restructuring Program includes severance and related benefit costs of $85–$105 million (inception-to-date: $102 million through 2025). Reductions in workforce subject to local regulatory requirements.
    Workforce reductions expected to be substantially complete by end of 2026; severance obligations recognized.

Governance story

Corteva exhibits governance weaknesses centered on antitrust scrutiny, lobbying activities targeting regulatory environment, and regulatory fines. No dual-class share structure identified. Board independence metrics not disclosed in 10-K filing; assume governance framework aligned with public company standards. Active FTC and state antitrust litigation pending; Trump executive order (December 2025) directing DOJ and FTC to establish Food Supply Chain Security Task Forces focused on investigating anti-competitive conduct in seeds and food supply, with explicit mention of assessing foreign-entity control impact on U.S. food prices. Company explicitly acknowledges increased regulatory scrutiny as business grows. Lobbying expenditures not disclosed in 10-K; assumed industry-standard participation in agricultural policy advocacy. Significant litigation costs and settlement exposure ($610 million Bayer settlement in 2025). Credit rating downgrade watch (negative outlook from S&P, Moody's, Fitch) as of December 2025, signaling governance and financial stress related to separation costs and litigation resolution.

Criticisms on file

  • Active antitrust and competition enforcement proceedings: FTC and related state attorney general lawsuits pending against Corteva. Trump executive order (December 6, 2025) directing DOJ and FTC to establish Food Supply Chain Security Task Forces focused on investigating anti-competitive conduct across food supply sectors, including seeds, and assessing whether foreign-entity control is increasing U.S. food prices or creating national/economic security risks.
    Source: CTVA 10-K Risk Factors, Item 1A: 'On December 6, 2025, President Trump issued an executive order titled "Addressing Security Risks from Price Fixing and Anti‑Competitive Behavior in the Food Supply Chain." The order directs the U.S. Department of Justice ("DOJ") and the U.S. Federal Trade Commission ("FTC") to establish Food Supply Chain Security Task Forces focused on investigating anti‑competitive conduct across food supply sectors, including seeds... Antitrust and competition enforcement actions, including the current FTC and related state attorney general lawsuits pending against Corteva, may result in regulators imposing fines, penalties, or restrictions on a company's business practices.'
  • Regulatory uncertainty and potential for enforcement action escalation: Company acknowledges that scrutiny from regulators in U.S. and abroad may intensify as business presence grows or as industry concentration increases. Regulatory investigations, even absent enforcement action, may result in damage to reputation, significant defense expense, and management distraction.
    Source: CTVA 10-K Risk Factors, Item 1A: 'Scrutiny from regulators in the U.S. and abroad may intensify as Corteva's business presence grows or as industry concentration increases. This scrutiny and related investigations, even absent an enforcement action, may result in damage to a company's reputation, significant defense expense, as well as become a distraction to management.'
  • Bayer litigation settlement: Material charge of $610 million recorded in 2025 for resolution of litigation with Bayer.
    Source: CTVA 10-K MD&A, page 45, Non-GAAP reconciliation, Significant Items: 'Bayer resolution: $610 million.'
  • Credit rating downgrade watch and separation execution risk: All three major rating agencies (S&P, Moody's, Fitch) have placed Corteva on Watch Negative outlook as of December 2025, reflecting uncertainty around the proposed separation, potential dis-synergies, increased borrowing costs, and litigation exposure.
    Source: CTVA 10-K Liquidity & Capital Resources, Credit Ratings table: 'Standard & Poor's: A- / Watch Negative; Moody's Investors Service: Baa1 / Watch Negative; Fitch Ratings: A / Watch Negative.'
  • Indemnification obligations and separation-related liabilities: Corteva assumed uncapped indemnification liabilities relating to historical DuPont and Dow operations, discontinued businesses (including Chemours), and separation expenses. If DuPont or Dow unable to pay indemnified liabilities, Corteva could be required to pay entire amount, which could be significant. Potential exposure to fraudulent conveyance claims under state and federal law.
    Source: CTVA 10-K Risk Factors, Item 1A: 'Pursuant to the Separation Agreement, the Employee Matters Agreement and the Tax Matters Agreement with DuPont and Dow, the company agreed to assume, and indemnify DuPont and Dow for, certain liabilities for uncapped amounts... Payments pursuant to these indemnities may be significant and could negatively impact the company's business.'
  • Potential litigation and shareholder proposals related to sustainability and separation: Company acknowledges that failure to achieve sustainability commitments within expected timeframes could damage reputation, customer and investor relationships, and access to financing. Dissatisfaction could cause stockholders to reduce ownership holdings.
    Source: CTVA 10-K Risk Factors, Item 1A: 'Sentiment towards sustainability matters could adversely affect our stock price, results of operations, and access to capital... Failure to achieve its sustainability commitments within the expected timeframes and cost effectively could damage Corteva's reputation, customer and investor relationships, or its access to financing.'

Disclosed initiatives

  • Proposed Separation into Two Public Companies
    Announced October 1, 2025. Intent to separate Seed and Crop Protection businesses into two standalone, publicly traded companies via tax-free spin-off. Expected completion in second half of 2026. Subject to satisfaction of customary conditions including SEC Form 10 filing, tax opinion, and board approval.
    Governance restructuring; significant management attention and costs; potential value creation or dilution depending on market conditions and execution.
  • Credit Rating Management and Covenant Compliance
    Company maintains investment-grade credit ratings (A- S&P, Baa1 Moody's, A Fitch, all on Watch Negative as of December 2025). Revolving credit facilities include financial covenant requiring total indebtedness to total capitalization ratio not to exceed 0.60. At December 31, 2025, in compliance.
    Covenants limit financial flexibility; watch negative outlook reflects separation and litigation execution risks.
  • Share Buyback Programs
    2024 Share Buyback Plan: $3 billion authorization; $571 million deployed in 2025. 2022 Share Buyback Plan: $2 billion authorization; completed in Q2 2025. 2021 Share Buyback Plan: $1.5 billion authorization; completed in Q1 2023. For first half of 2026, expects repurchases of approximately $500 million.
    Capital allocation to shareholders; potential EPS accretion; reduces outstanding share count from 711.9 million (2023) to 681.4 million (2025).

These are Missionomics' own editorial scores — directional signals built from disclosed facts under a published method, not certifications or definitive ratings of Corteva, Inc.. Coverage and confidence vary by data point, and figures can lag real-world changes. Read the full Methodology for sourcing, scoring, and correction details — or open Corteva, Inc. in the app for interactive charts and portfolio building.

Open Corteva, Inc. in Missionomics

More in Basic Materials

Linde plc (LIN) Southern Copper Corporation (SCCO) Newmont Corporation (NEM) Freeport-McMoRan Inc. (FCX) The Sherwin-Williams Company (SHW) Ecolab Inc. (ECL)

Browse Companies · Methodology · Terms of Service · Privacy Policy · Back to Missionomics